(Q39679776)

13 September 2017

MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma (English)

1 reference

13 September 2017

0 references

Stefan M Pfister

13

0 references

Andrey Korshunov

12

object named as

Andrey Korshunov

1 reference

13 September 2017

Sarra L Ryan

1

1 reference

13 September 2017

Ed C Schwalbe

2

1 reference

13 September 2017

Michael Cole

3

1 reference

13 September 2017

Yuan Lu

4

1 reference

13 September 2017

Meryl E Lusher

5

1 reference

13 September 2017

Hisham Megahed

6

1 reference

13 September 2017

Kieran O'Toole

7

1 reference

13 September 2017

Sarah Leigh Nicholson

8

1 reference

13 September 2017

Laszlo Bognar

9

1 reference

13 September 2017

Miklos Garami

10

1 reference

13 September 2017

Peter Hauser

11

1 reference

13 September 2017

Daniel Williamson

14

1 reference

13 September 2017

Roger E Taylor

15

1 reference

13 September 2017

David W Ellison

16

1 reference

13 September 2017

Simon Bailey

17

1 reference

13 September 2017

Steven C Clifford

18

1 reference

13 September 2017

language of work or name

1 reference

3 December 2011

1 reference

13 September 2017

Acta Neuropathologica

1 reference

13 September 2017

123

1 reference

13 September 2017

501-513

1 reference

13 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-011-0923-y

13 September 2017

0 references

cites work

Transcriptional regulation and transformation by Myc proteins

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Gender affects survival for medulloblastoma only in older children and adults: a study from the Surveillance Epidemiology and End Results Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

The WHO classification of tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Medulloblastoma comprises four distinct molecular variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

c-MYC: more than just a matter of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Rapid diagnosis of medulloblastoma molecular subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Pleiotropic role for MYCN in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0923-Y

10.1007/S00401-011-0923-Y

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference